{"id":77044,"date":"2021-10-21T16:51:00","date_gmt":"2021-10-21T16:51:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/"},"modified":"2021-10-21T16:51:00","modified_gmt":"2021-10-21T16:51:00","slug":"el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/","title":{"rendered":"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s’actualitzin en oncologia hematol\u00f2gica"},"content":{"rendered":"

\u00a0<\/p>\n

\u2022 <\/span>La inscripci\u00f3<\/strong> es pot realitzar fins al 4 de novembre<\/strong> a trav\u00e9s de la web institucional del COFB www.cofb.org<\/a> (apartat \u201cActivitats\u201d)<\/strong><\/div>\n
\u00a0<\/div>\n
\u2022 <\/span>L’oncologia hematol\u00f2gica s’abordar\u00e0 des del punt de vista terap\u00e8utic<\/strong> (gesti\u00f3 i tractament dels c\u00e0ncers hematol\u00f2gics), psicol\u00f2gic<\/strong> (suport emocional en el tractament actiu) i farmac\u00e8utic<\/strong> (educaci\u00f3 sanit\u00e0ria del pacient en l’era dels tractaments orals), tot aix\u00f2 de la m\u00e0 de ponents de reconeguda traject\u00f2ria<\/div>\n
\u00a0<\/div>\n
\u2022 <\/span>El curs consta d’1 sessi\u00f3 setmanal durant 5 setmanes<\/strong>, que s’impartiran a trav\u00e9s d’un webinar en directe, amb un enfocament teoricopr\u00e0ctic i torn de preguntes per a promoure el debat, la reflexi\u00f3 conjunta i la interacci\u00f3 entre ponents i participants<\/div>\n
\u00a0<\/div>\n
Barcelona, 21 d’octubre de 2021<\/em>. El pr\u00f2xim 4 de novembre <\/strong>comen\u00e7a la formaci\u00f3 \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d<\/strong>, organitzada pel Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), juntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC). El curs, patrocinat per Astellas<\/strong> y Janssen<\/strong>, est\u00e0 dirigida a farmac\u00e8utics hospitalaris<\/strong> i \u00e9s una de les novetats del programa de formaci\u00f3 continuada 2021-2022 del COFB<\/strong>. Consta d’un total de 5 sessions (4, 11, 18 i 25 de novembre i 2 de desembre), que s’impartiran a trav\u00e9s d’un <\/em>webinar <\/em>en directe<\/strong>, amb un enfocament teoricopr\u00e0ctic i torn de preguntes per promoure el debat, la reflexi\u00f3 conjunta i la interacci\u00f3 entre ponents i participants.<\/div>\n
\u00a0<\/div>\n
La inscripci\u00f3<\/strong>, que \u00e9s gratu\u00efta per a col\u00b7legiats dels Col\u00b7legis de Farmac\u00e8utics i membres de la Societat Catalana de Farm\u00e0cia Cl\u00ednica<\/strong>, es pot realitzar a trav\u00e9s de la web institucional del COFB www.cofb.org<\/a> (apartat \u201cActivitats\u201d)<\/strong>.<\/div>\n
\u00a0<\/div>\n
Abordatge transversal i multidisciplinari amb experts de reconeguda traject\u00f2ria<\/strong><\/u><\/div>\n
La formaci\u00f3 s’ha plantejat des d’una perspectiva multidisciplin\u00e0ria<\/strong>, ja que entre els ponents trobem a metges, psic\u00f2legs i farmac\u00e8utics<\/strong>, tots ells de reconeguda traject\u00f2ria<\/strong> i amb una \u00e0mplia experi\u00e8ncia<\/strong> dins del seu \u00e0mbit. Aix\u00ed, l’oncologia hematol\u00f2gica s’abordar\u00e0 des del punt de vista terap\u00e8utic (gesti\u00f3 i tractament dels c\u00e0ncers hematol\u00f2gics), psicol\u00f2gic (suport emocional en el tractament actiu) i farmac\u00e8utic (educaci\u00f3 sanit\u00e0ria del pacient en l’era dels tractaments orals).<\/div>\n
\u00a0<\/div>\n
Dins del primer bloc, Albert Alt\u00e9s<\/strong>, cap del servei d’Hematologia de Althaia i president de la Societat Catalana d’Hematologia, abordar\u00e0 la leuc\u00e8mia linfoc\u00edtica cr\u00f2nica<\/strong>; Ana Mar\u00edn<\/strong>, de la unitat de limfomes del Servei d’Hematologia de l’Hospital Vall d\u2019Hebron, tractar\u00e0 el limfoma de les c\u00e8l\u00b7lules del mantell<\/strong>; i Carlos Fern\u00e1ndez de Larrera<\/strong>, consultor de la unitat de mieloma i amiloidosis del Servei d’Hematologia de l’Hospital Cl\u00ednic de Barcelona, abordar\u00e0 la malaltia de Waldenstr\u00f6m<\/strong>. D’altra banda, Mercedes Gironella, de la unitat de gammapat\u00edas monoclonals del Servei d’Hematologia de l’Hospital Vall d\u2019Hebron, aprofundir\u00e0 en el mieloma m\u00faltiple<\/strong>; i Ana Garrido<\/strong>, metgessa adjunta de gu\u00e0rdies d’Hematologia Cl\u00ednica del Servei d’Hematologia de l’Hospital Sant Pau, se centrar\u00e0 en la leuc\u00e8mia mieloide aguda<\/strong>.<\/div>\n
\u00a0<\/div>\n
D’altra banda, la psic\u00f2loga Judit L\u00f3pez<\/strong>, experta en tractaments psicoemocionals a pacients oncol\u00f2gics, se centrar\u00e0 en la import\u00e0ncia del suport emocional en el tractament actiu<\/strong>.<\/div>\n
\u00a0<\/div>\n
Finalment, des de l’\u00e0mbit farmac\u00e8utic<\/strong>, Estela Moreno<\/strong>, farmac\u00e8utica de l’Hospital Sant Pau i coordinadora del grup de farm\u00e0cia oncol\u00f2gica de la Societat Espanyola de Farm\u00e0cia Hospital\u00e0ria, aprofundir\u00e0 en els aspectes clau en l’educaci\u00f3 del pacient<\/strong> en l’era dels tractaments orals<\/strong>.<\/div>\n
\u00a0<\/div>\n
La import\u00e0ncia de la formaci\u00f3 en oncologia hematol\u00f2gica<\/strong><\/u><\/div>\n
En els \u00faltims anys, s’han produ\u00eft novetats terap\u00e8utiques<\/strong> en els tractaments contra els c\u00e0ncers relacionats amb la sang i s’han aplicat noves estrat\u00e8gies als pacients. L’envelliment de la poblaci\u00f3<\/strong> i una pres\u00e8ncia m\u00e9s acusada d’aquesta mena de c\u00e0ncers en el pacient anci\u00e0 fr\u00e0gil <\/strong>afegeix complexitat a la gesti\u00f3.<\/div>\n
\u00a0<\/div>\n
En aquest sentit, David Conde<\/strong>, vocal d’Hospitals del Col\u00b7legi de Farmac\u00e8utics de Barcelona, explica que \u201cen els \u00faltims anys hem assistit a novetats en diferents patologies hematol\u00f2giques<\/strong>, amb nous abordatges de tractaments sist\u00e8mics que, conseq\u00fcentment, han canviat el curs cl\u00ednic de diferents malalties\u201d. I destaca que \u201ca causa de l’augment de noves mol\u00e8cules disponibles<\/strong> considerem que \u00e9s imprescindible posar-les en context i con\u00e8ixer com s’integren en els protocols farmacoterap\u00e8utics d’aquestes patologies neopl\u00e0siques\u201d. Per a aix\u00f2, \u201ccomptarem amb la pres\u00e8ncia d’experts<\/strong> en cadascuna d’aquestes patologies perqu\u00e8 ens il\u00b7lustrin el panorama actual en la pr\u00e0ctica cl\u00ednica<\/strong> i del que est\u00e0 per arribar, fent \u00e8mfasi tamb\u00e9 en la implicaci\u00f3 del farmac\u00e8utic <\/strong>i la seva actuaci\u00f3\u201d.<\/div>\n
\u00a0<\/div>\n
Amb el patrocini de:<\/strong><\/div>\n

\u00a0\u2022 La inscripci\u00f3 es pot realitzar fins al 4 de novembre a trav\u00e9s de la web institucional del COFB www.cofb.org (apartat \u201cActivitats\u201d)<\/p>\n

\u00a0<\/p>\n

\u2022 L’oncologia hematol\u00f2gica s’abordar\u00e0 des del punt de vista terap\u00e8utic (gesti\u00f3 i tractament dels c\u00e0ncers hematol\u00f2gics), psicol\u00f2gic (suport emocional en el tractament actiu) i farmac\u00e8utic (educaci\u00f3 sanit\u00e0ria del pacient en l’era dels tractaments orals), tot aix\u00f2 de la m\u00e0 de ponents de reconeguda traject\u00f2ria<\/p>\n

\u00a0<\/p>\n

\u2022 El curs consta d’1 sessi\u00f3 setmanal durant 5 setmanes, que s’impartiran a trav\u00e9s d’un webinar en directe, amb un enfocament teoricopr\u00e0ctic i torn de preguntes per a promoure el debat, la reflexi\u00f3 conjunta i la interacci\u00f3 entre ponents i participants<\/p>\n

\u00a0<\/p>\n

Barcelona, 21 d’octubre de 2021. El pr\u00f2xim 4 de novembre comen\u00e7a la formaci\u00f3 \u201cActualitzaci\u00f3 en oncologia hematol\u00f2gica\u201d, organitzada pel Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), juntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC). El curs, patrocinat per Astellas y Janssen, est\u00e0 dirigida a farmac\u00e8utics hospitalaris i \u00e9s una de les novetats del programa de formaci\u00f3 continuada 2021-2022 del COFB. Consta d’un total de 5 sessions (4, 11, 18 i 25 de novembre i 2 de desembre), que s’impartiran a trav\u00e9s d’un webinar en directe, amb un enfocament teoricopr\u00e0ctic i torn de preguntes per promoure el debat, la reflexi\u00f3 conjunta i la interacci\u00f3 entre ponents i participants.<\/p>\n

\u00a0<\/p>\n

La inscripci\u00f3, que \u00e9s gratu\u00efta per a col\u00b7legiats dels Col\u00b7legis de Farmac\u00e8utics i membres de la Societat Catalana de Farm\u00e0cia Cl\u00ednica, es pot realitzar a trav\u00e9s de la web institucional del COFB www.cofb.org (apartat \u201cActivitats\u201d).<\/p>\n

\u00a0<\/p>\n

Abordatge transversal i multidisciplinari amb experts de reconeguda traject\u00f2ria<\/p>\n

La formaci\u00f3 s’ha plantejat des d’una perspectiva multidisciplin\u00e0ria, ja que entre els ponents trobem a metges, psic\u00f2legs i farmac\u00e8utics, tots ells de reconeguda traject\u00f2ria i amb una \u00e0mplia experi\u00e8ncia dins del seu \u00e0mbit. Aix\u00ed, l’oncologia hematol\u00f2gica s’abordar\u00e0 des del punt de vista terap\u00e8utic (gesti\u00f3 i tractament dels c\u00e0ncers hematol\u00f2gics), psicol\u00f2gic (suport emocional en el tractament actiu) i farmac\u00e8utic (educaci\u00f3 sanit\u00e0ria del pacient en l’era dels tractaments orals).<\/p>\n

\u00a0<\/p>\n

Dins del primer bloc, Albert Alt\u00e9s, cap del servei d’Hematologia de Althaia i president de la Societat Catalana d’Hematologia, abordar\u00e0 la leuc\u00e8mia linfoc\u00edtica cr\u00f2nica; Ana Mar\u00edn, de la unitat de limfomes del Servei d’Hematologia de l’Hospital Vall d\u2019Hebron, tractar\u00e0 el limfoma de les c\u00e8l\u00b7lules del mantell; i Carlos Fern\u00e1ndez de Larrera, consultor de la unitat de mieloma i amiloidosis del Servei d’Hematologia de l’Hospital Cl\u00ednic de Barcelona, abordar\u00e0 la malaltia de Waldenstr\u00f6m. D’altra banda, Mercedes Gironella, de la unitat de gammapat\u00edas monoclonals del Servei d’Hematologia de l’Hospital Vall d\u2019Hebron, aprofundir\u00e0 en el mieloma m\u00faltiple; i Ana Garrido, metgessa adjunta de gu\u00e0rdies d’Hematologia Cl\u00ednica del Servei d’Hematologia de l’Hospital Sant Pau, se centrar\u00e0 en la leuc\u00e8mia mieloide aguda.<\/p>\n

\u00a0<\/p>\n

D’altra banda, la psic\u00f2loga Judit L\u00f3pez, experta en tractaments psicoemocionals a pacients oncol\u00f2gics, se centrar\u00e0 en la import\u00e0ncia del suport emocional en el tractament actiu.<\/p>\n

\u00a0<\/p>\n

Finalment, des de l’\u00e0mbit farmac\u00e8utic, Estela Moreno, farmac\u00e8utica de l’Hospital Sant Pau i coordinadora del grup de farm\u00e0cia oncol\u00f2gica de la Societat Espanyola de Farm\u00e0cia Hospital\u00e0ria, aprofundir\u00e0 en els aspectes clau en l’educaci\u00f3 del pacient en l’era dels tractaments orals.<\/p>\n

\u00a0<\/p>\n

La import\u00e0ncia de la formaci\u00f3 en oncologia hematol\u00f2gica<\/p>\n

En els \u00faltims anys, s’han produ\u00eft novetats terap\u00e8utiques en els tractaments contra els c\u00e0ncers relacionats amb la sang i s’han aplicat noves estrat\u00e8gies als pacients. L’envelliment de la poblaci\u00f3 i una pres\u00e8ncia m\u00e9s acusada d’aquesta mena de c\u00e0ncers en el pacient anci\u00e0 fr\u00e0gil afegeix complexitat a la gesti\u00f3.<\/p>\n

\u00a0<\/p>\n

En aquest sentit, David Conde, vocal d’Hospitals del Col\u00b7legi de Farmac\u00e8utics de Barcelona, explica que \u201cen els \u00faltims anys hem assistit a novetats en diferents patologies hematol\u00f2giques, amb nous abordatges de tractaments sist\u00e8mics que, conseq\u00fcentment, han canviat el curs cl\u00ednic de diferents malalties\u201d. I destaca que \u201ca causa de l’augment de noves mol\u00e8cules disponibles considerem que \u00e9s imprescindible posar-les en context i con\u00e8ixer com s’integren en els protocols farmacoterap\u00e8utics d’aquestes patologies neopl\u00e0siques\u201d. Per a aix\u00f2, \u201ccomptarem amb la pres\u00e8ncia d’experts en cadascuna d’aquestes patologies perqu\u00e8 ens il\u00b7lustrin el panorama actual en la pr\u00e0ctica cl\u00ednica i del que est\u00e0 per arribar, fent \u00e8mfasi tamb\u00e9 en la implicaci\u00f3 del farmac\u00e8utic i la seva actuaci\u00f3\u201d.<\/p>\n

\u00a0<\/p>\n

Amb el patrocini de:\u00a0\u00a0COFB.ORG<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00a0 \u2022 La inscripci\u00f3 es pot realitzar fins al 4 de novembre a trav\u00e9s de la web institucional del COFB www.cofb.org (apartat \u201cActivitats\u201d) \u00a0 \u2022 L’oncologia hematol\u00f2gica s’abordar\u00e0 des del punt de vista terap\u00e8utic (gesti\u00f3 i tractament dels c\u00e0ncers hematol\u00f2gics), psicol\u00f2gic (suport emocional en el tractament actiu) i farmac\u00e8utic (educaci\u00f3 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77044","post","type-post","status-publish","format-standard","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"\nEl COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s'actualitzin en oncologia hematol\u00f2gica - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s'actualitzin en oncologia hematol\u00f2gica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 \u2022 La inscripci\u00f3 es pot realitzar fins al 4 de novembre a trav\u00e9s de la web institucional del COFB www.cofb.org (apartat \u201cActivitats\u201d) \u00a0 \u2022 L’oncologia hematol\u00f2gica s’abordar\u00e0 des del punt de vista terap\u00e8utic (gesti\u00f3 i tractament dels c\u00e0ncers hematol\u00f2gics), psicol\u00f2gic (suport emocional en el tractament actiu) i farmac\u00e8utic (educaci\u00f3 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-21T16:51:00+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s’actualitzin en oncologia hematol\u00f2gica\",\"datePublished\":\"2021-10-21T16:51:00+00:00\",\"dateModified\":\"2021-10-21T16:51:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/\"},\"wordCount\":1625,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/\",\"name\":\"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s'actualitzin en oncologia hematol\u00f2gica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"datePublished\":\"2021-10-21T16:51:00+00:00\",\"dateModified\":\"2021-10-21T16:51:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s’actualitzin en oncologia hematol\u00f2gica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s'actualitzin en oncologia hematol\u00f2gica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/","og_locale":"ca_ES","og_type":"article","og_title":"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s'actualitzin en oncologia hematol\u00f2gica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 \u2022 La inscripci\u00f3 es pot realitzar fins al 4 de novembre a trav\u00e9s de la web institucional del COFB www.cofb.org (apartat \u201cActivitats\u201d) \u00a0 \u2022 L’oncologia hematol\u00f2gica s’abordar\u00e0 des del punt de vista terap\u00e8utic (gesti\u00f3 i tractament dels c\u00e0ncers hematol\u00f2gics), psicol\u00f2gic (suport emocional en el tractament actiu) i farmac\u00e8utic (educaci\u00f3 […]","og_url":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2021-10-21T16:51:00+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"8 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s’actualitzin en oncologia hematol\u00f2gica","datePublished":"2021-10-21T16:51:00+00:00","dateModified":"2021-10-21T16:51:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/"},"wordCount":1625,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/","url":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/","name":"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s'actualitzin en oncologia hematol\u00f2gica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"datePublished":"2021-10-21T16:51:00+00:00","dateModified":"2021-10-21T16:51:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2021\/10\/21\/el-cof-de-barcelona-organitza-una-formacio-perque-farmaceutics-hospitalaris-sactualitzin-en-oncologia-hematologica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"El COF de Barcelona organitza una formaci\u00f3 perqu\u00e8 farmac\u00e8utics hospitalaris s’actualitzin en oncologia hematol\u00f2gica"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 \u2022 La inscripci\u00f3 es pot realitzar fins al 4 de novembre a trav\u00e9s de la web institucional del COFB www.cofb.org (apartat \u201cActivitats\u201d) \u00a0 \u2022 L’oncologia hematol\u00f2gica s’abordar\u00e0 des del punt de vista terap\u00e8utic (gesti\u00f3 i tractament dels c\u00e0ncers hematol\u00f2gics), psicol\u00f2gic (suport emocional en el tractament actiu) i farmac\u00e8utic (educaci\u00f3 […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=77044"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77044\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=77044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=77044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=77044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}